Leidos · 7 hours ago
Quantum Photonics Engineer
Leidos has a new and exciting opportunity for a Quantum Photonics Engineer in their Intel Sector - Cyber & Analytics Business Area. This role focuses on advancing design capabilities in integrated photonics, involving simulation, design, and layout work for quantum applications while collaborating with circuit designers and test engineers to achieve project goals.
ComputerGovernmentInformation ServicesInformation TechnologyNational SecuritySoftware
Responsibilities
Simulate and design photonics components
Develop photonic integrated circuits through Python programming
Collaborate with fabrication and test teams to deliver promising solutions
Qualification
Required
Degree in physics, engineering, or other equivalent area of expertise and 4+ year of experience
Strong proficiency in object-oriented programming and software development best practices
Experience with optimization of photonic components using simulation tools (Lumerical, Tidy3D, or equivalent)
Familiarity with GDSFactory, KLayout, or similar design tools
Experience with open-ended numerical simulations and optimizations
Strong analysis, design, and problem-solving skills
Expert in Python programming
US citizenship with an active Top Secret clearance is required
Preferred
Team-based software engineering experience (version control, concurrent development, etc.)
Expertise and experimental background in nonlinear optics, atomic physics, quantum information science, and/or quantum photonics
Experience with nanofabrication processes and process design kits
Experience with design and packaging of heterogeneous devices
Experience creating GDSII/OASIS files programmatically
Strong background in data analysis and visualization
Benefits
Paid Time Off
11 paid Holidays
401K with a 6% company match and immediate vesting
Flexible Schedules
Discounted Stock Purchase Plans
Technical Upskilling
Education and Training Support
Parental Paid Leave
And much more.
Company
Leidos
Leidos is a Fortune 500® innovation company rapidly addressing the world’s most vexing challenges in national security and health.
Funding
Current Stage
Public CompanyTotal Funding
unknown2025-02-20Post Ipo Debt
2013-09-17IPO
Recent News
MarketScreener
2025-12-16
2025-12-16
Company data provided by crunchbase